No linkage of the lipoprotein lipase locus to hypertension in Caucasians

Journal of Hypertension

Volumn 17, Issue 1, 1999, Pages 39-43

  Hunt, Steven C ^a   Province, Michael A ^b   Atwood, Larry D ^c   Sholinsky, Phyliss ^d   Lalouel, Jean Marc ^a   Rao, D C ^b   Williams, Roger R ^a   Leppert, Mark F ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Blood pressure; Genetics; Lipids

Indexed keywords

DNA MARKER; LIPOPROTEIN LIPASE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CHINESE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC LINKAGE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SIBLING; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 0033020020     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917010-00007     Document Type: Article

References (22)

1. Babirak SP, herbs PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989; 9:326-334.
2. Wilson DE, Edwards CQ, Chan IF. Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency. Metab Clin Exp 1983; 32:1107-1114.
3. Wilson DE, Emi M, Iverius PH, Hata A, Wu LL, Hillas E, et al. Phenotypic expression of heterozygous LPL deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990; 86:735-750.
4. Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991; 90 (Suppl 2A):7S-12S.
5. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, et al. Familial dystipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259:3579-3536.
6. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996; 45:699-706.
7. Wu D-A, Bu X, Warden CH. Shen DDC, Jeng C-Y, Sheu WHH, et al. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene on chromosome 8p22. J Clin Invest 1996; 97:2111-2118.
8. Cantor RM, Davis RC, Hsueh WA, Raffel LR, Buchanan TA, Saad MF, et al. Linkage of systolic blood pressure (SBP) to the lipoprotein lipase (LPL) locus confirmed in Mexican American hypertension families: evidence for the pleiotropic effect of a gene contributing to the metabolic syndrome [abstract]. Am J Hum Genet 1997; 61:A270.
9. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143:1219-1228.
10. Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
11. Williams RR, Hunt SC, Barlow GK, Chamberlain RM, Weinberg AD, Cooper HP, et al. Health family trees: a tool for finding and helping young members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health 1988; 78:1283-1286.
12. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 380:152-154.
13. Odelberg S, White R. A method for accurate amplification of polymorphic CA-repeat sequences: PCR methods and applications, vol 3. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1993. pp. 7-12.
14. S.A.G.E. Statistical analysis for genetic epidemiology, release 2.2. Cleveland, Ohio: Department of Epidemiology and Biostatistics, Case Western Reserve University; 1994.
15. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58:1347-1363.
16. Gagne E. Genest JJ, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb 1994; 14:1250-1257.
17. Nevin DN, Brunzell JD, Deeb SS. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994; 14:869-873.
18. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 1997; 96:733-740.
19. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA 1991; 265:2079-2084.
20. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 20:38-45.
21. Corrocher R, Steinmayr M, Ruzzenente O, Brugnara C, Bertinato L, Mazzi M, et al. Elevation of red cell sodium-lithium countertransport in hypertipidemias. Life Sci 1985; 36:649-655.
22. Hunt SC, Williams RR, Smith JB, Ash KO. Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. Hypertension 1986; 8:30-36.